Owner Merck Sharp & Dohme Corp.

Inventors Walsh, Thomas F.; Madsen-Duggan, Christina B.; Debenham, John S.; Hale, Jeffrey J.; Clements, Matthew J.

Agent Spruson & Ferguson

Pub. Number AU-A-2009225869

PCT Pub. Number WO2009/117269

Priority 61/069,864 18.03.08 US; 61/192,918 23.09.08 US

Filing date 9 March 2009

Wipo publication date 24 September 2009

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group